Where Is Life Sciences Heading? Biotech, Health Tech, Pharma and the Next Frontier

Curated Dialogue

Health & Life Sciences

Life sciences are advancing rapidly, driven by breakthroughs in biology, data, and AI. Yet the path from innovation to real-world impact remains complex, with regulatory, economic, and systemic barriers slowing adoption. This session examines where the sector stands today — what is translating into value, what remains stuck, and how the landscape is evolving across biotech, pharma, and health systems.

SPEAKERS:

We are in the process of finalizing the agenda. Stay tuned for any updates.

Christine Gould

GIGA

Peter Kash

Camelot Bio Capital

Renee Deehan

Inside Tracker

Sergio Dompè

Dompé farmaceutici

< Back